Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04260997Not ApplicableCompleted

Effect of a Probiotic, Lactobacillus Gasseri BNR17, on Body Composition and Weight Management in Overweight Adults

Role: lead

NCT03543982Not ApplicableCompleted

Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

Role: lead

NCT02734706Not ApplicableCompleted

Efficacy of a LRC™ (L. Reuteri NCIMB 30242) Capsule on Managing Cholesterol in Adults

Role: lead

NCT02418507Phase 2Completed

An Evaluation of the Effectiveness of a Proprietary Probiotic Blend on Functional Constipation

Role: collaborator

All 4 trials loaded